| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |